8DZC
Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor 17
Summary for 8DZC
Entry DOI | 10.2210/pdb8dzc/pdb |
Descriptor | 3C-like proteinase nsp5, (3,5-difluorophenyl)methyl {(3S)-1-[(2S)-1-({(2S,3R)-4-(cyclopropylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-6-oxopiperidin-3-yl}carbamate, GLYCEROL, ... (4 entities in total) |
Functional Keywords | covid, covid19, covid-19, sars, sars cov2, cov, ncov 19, coronavirus, main protease, 3cl, mpro, pro, gc376, calpain inhibitor ii, leupeptin, calpain, aldehyde, gc-376, 3cl-like, a-ketoamide, alpheketoamide, alpha, ketoamide, petidometic, protease, cysteine, hydrolase-hydrolase inhibitor complex, viral protein-inhibitor complex, viral protein/inhibitor |
Biological source | Severe acute respiratory syndrome coronavirus 2 |
Total number of polymer chains | 1 |
Total formula weight | 34539.31 |
Authors | |
Primary citation | Wang, L.,Ma, C.,Sacco, M.D.,Xue, S.,Mahmoud, M.,Calcul, L.,Chen, Y.,Wang, J.,Cai, J. Development of the Safe and Broad-Spectrum Aldehyde and Ketoamide Mpro inhibitors Derived from the Constrained alpha , gamma-AA Peptide Scaffold. Chemistry, 29:e202300476-e202300476, 2023 Cited by PubMed: 36920943DOI: 10.1002/chem.202300476 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.2 Å) |
Structure validation
Download full validation report